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Abstract 
Background: Whereas an increase of neck circumference (NC) had been recently identified as a new independent 
cardiovascular disease (CVD) and metabolic syndrome risk factor, similar assessments concerning screen-detected 
diabetes mellitus (SDDM) have not been made. Thyroid gland volume (ThV) can potentially affect NC however the 
significance of this influence concerning the risk of NC-related disease is unknown.
Methods: We performed a ThV-adjusted evaluation of NC within a population-based investigation of SDDM and 
impaired glucose regulation (IGR) prevalence. This study contains fasting plasma glucose (FPG) and 75 g 2-h glucose 
tolerance test results (2-hPG) of 196 residents of Kyiv region, Ukraine, randomly selected from the rural population 
older than 44 y.o. who were not registered as diabetes mellitus patients. Standard anthropometric (height; weight; 
blood pressure; waist, hip circumferences), NC and ultrasonography ThV measurements were performed, hypoten-
sive medication, CVD events and early life nutrition history considered. HbA1c was measured, if FPG/2-hPG reached 
7.0/11.1 mmol/l respectively; HbA1c level 6.5 % was considered to be SDDM diagnostic; IGR if FPG/2-hPG reached 
6.1/7.8 but less than 7.0/11.1 mmol/l respectively.
Results: Neck circumference among women with normal FPG/2-hPG was 35 (33–36) cm, IGR 36 (34.5–38) cm, SDDM 
HbA1c < 6.5 % 42 (40–43) cm, HbA1c > 6.5 % 42.5 (40–44) cm, p < 0.001, and for men from the same groups 38.5 
(36.5–41.5) cm; 39 (37–42) cm; 42 (40–43) cm; 42.5 (40–44) cm, p = 0.063; medians (QI–QIII). Gender-adjusted logistic 
regression OR for SDDM HbA1c > 6.5 % vs. normal FPG/2-hPG category depending of NC as a continued variable, 
equaled to 1.60 (95 % CI 1.27–2.02) per cm. Additional adjusting by ThV, body mass or waist/hip index, high blood 
pressure, acute CVD events, or starvation history did not significantly influence this risk.
Conclusion: Neck circumference is a new risk factor of SDDM that is independent from other indicators of adipose 
tissue distribution as well as from the ThV.
Keywords: Neck circumference, Screen-detected diabetes mellitus, Thyroid gland volume, Body mass index, Waist to 
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Background
The importance of different fat deposition types, as risk 
factors for developing metabolic disorders and athero-
sclerosis was established in 1956 by Jean Vague, however 
the measurements of corresponding circumferences and 
their quantitative assessment were not performed [1].
Later in 1984, Arthur Hartz, David Rupley, and Alfred 
Rimm revealed that increasing of the waist circumfer-
ence (WC) to hip circumference (HC) ratio (WC/HC) 
was positively associated with having diabetes and/or 
arterial hypertension or gall bladder disorders, based on 
questionnaire data of 21,056 women aged 40–59, who 
were members of a weight-loss program [2]. Shortly 
after, questionnaire data of a similar, but twice larger 
group of women, obtained by Freedman and Rimm [3] 




*Correspondence:  nikhalangot@ukr.net 
2 Komisarenko Institute of Endocrinology and Metabolism, Vyshgorodska 
69, Kiev 04114, Ukraine
Full list of author information is available at the end of the article
Page 2 of 8Khalangot et al. Diabetol Metab Syndr  (2016) 8:12 
associated with neck circumference (NC). The presence 
of goiter, quantitative parameters of thyroid gland, or life-
style characteristics were not taken into account in this 
study [3].
Strangely, unlike WC/HC ratio that has long been a 
routine test to assess the risk of type 2 diabetes mellitus 
(T2D) and cardiovascular disease (CVD) development 
[4, 5], an increase of NC is not known as a T2D risk fac-
tor. Just recently it was shown that NC is a predictor of 
metabolic syndrome in short-sleeping obese men and 
women and even addition of NC to the definition of 
metabolic syndrome was proposed for consideration [6]. 
Whereas an increase of NC has been recently determined 
as a new independent risk factor for CVD and meta-
bolic syndrome [7–9], we are not aware of any similar 
cross-sectional assessments concerning T2D risk. When 
our manuscript was already being reviewed, results of a 
prospective, community-based cohort study of Korean 
adults were published. These results indicate a negative 
impact from large neck circumference in the develop-
ment of diabetes mellitus [10].
Cross-sectional risk assessment of NC increase is not 
provided in the Korean study, and some potentially sub-
stantial adjusting, for such factors as thyroid volume or 
early development conditions was not performed. The 
issue of the significance of this new anthropometric indi-
cator for assessing risks for screen-detected diabetes mel-
litus (SDDM) during population-based studies in Europe 
remains open.
We performed a NC assessment, adjusted by thyroid 
size, within a recent (2013) screen-based investigation of 
SDDM (which is usually T2D) and impaired glucose reg-
ulation (IGR) epidemiology in rural Ukraine [11]. Ethnic 
as well as other territorial factors, including early devel-
opment circumstances can affect the feasibility of risk 
factors and T2D frequency [12–14]. Therefore an evalua-
tion of T2D risk factors in Ukraine, where the population 
suffered from mass starvation several times during the 
twentieth century [15] becomes even more significant, 
as the estimates of population decline due to the famine 
range from 2.7 to 3.9 million [16–18].
Methods
Diabetes and IGR (pre-diabetes) screening was con-
ducted between Jul 2013 and Nov 2014. In total, 202 
rural residents over 44 years of age, not registered as T2D 
patients, were randomly selected. Relevant lists of resi-
dents from two towns, provided by family doctors were 
used for randomization. Patients were selected using 
random number tables [19], and received an invitation 
to take part in the study. If the patients did not give con-
sent to take part, the invitation was forwarded to the next 
person in the randomized list. This study contains test 
results of 196 residents of Andriivka and Kopyliv villages 
(Kyiv region), who permanently live in the above commu-
nities and signed the informed consent form. All those 
involved, including the district endocrinologist and fam-
ily physicians took part in the study as volunteers. The 
study protocol was approved by the ethics committee of 
the Institute of Endocrinology and Metabolism, National 
Academy of Medical Sciences, Ukraine. After signing the 
informed consent forms the participants filled out ques-
tionnaires, providing information about current treat-
ment and lifestyle, as well as about the fact of starvation 
in their family in 1930s and/or 1946. One hundred and 
fifty nine persons answered the question about starvation 
of parental family, including 73 born before 1947. Among 
them 62 persons answered positive about starvation of 
parental family. Sufficient physical activity level (30 min/
day) was determined in accordance with current T2D 
prevention guidelines [20].
Anthropometric measurements and glucose toler-
ance tests were performed. Glicosylated hemoglobin 
levels (HbA1c) was measured, if fasting/2 h plasma glu-
cose reached 7.0/11.1  mmol/l respectively; HbA1c level 
6.5  % was considered to be diabetes mellitus diagnos-
tic. IGR (prediabetes) was considered in case if fasting 
plasma glucose reached 6.1/7.8  mmol/l but was below 
7.0/11.1 mmol/l respectively.
Anthropometric measurements
Body mass was measured using well-tried electronic 
scales, height—using standard portable stadiometer. 
Waist circumference (WC), hip circumference (HC), and 
neck circumference (NC) were measured with a flexible 
measuring tape at maximum transverse size in standing 
position. NC was measured above the cricothyroid carti-
lage to 5 mm accuracy.
Body mass index (BMI) was determined as a relation 
of body mass in kilograms to squared height in meters. 
To measure arterial blood pressure (BP) we assessed the 
Korotkoff sounds using operational blood pressure moni-
tors from corresponding family medicine clinics. BP was 
measured twice, with an interval of 5 min. If there was a 
difference of more than 10 mm we made a third measure-
ment. The mean value of these two/three measurements 
was counted. High BP was determined as 140/90 mmHg 
and above, or by the fact of hypotensive drug treatment. 
The blood sampling was done after at least 10 h of fasting 
and 2  h after taking a glucose solution (75  g of glucose 
in 200 ml of water). Blood plasma was quickly separated 
with a centrifuge and stored in a cold environment for 
further testing during 24  h. Glucose and HbA1c levels 
were determined by standard methods and in a certified 
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lab: glucose oxidase method was used for glucose testing. 
HbA1c levels were assessed using ClOVER A1c (Inforia 
Co., Ltd.) system that uses boronate resin to bind HbA1c.
Thyroid ultrasonography studies were performed and 
interpreted by the same experienced radiologist (IL), 
using the same equipment with a linear probe (Terason 
Ultrasound, Burlington, MA). The subjects were exam-
ined in supine position with the neck extended. Thyroid 
volume was measured as reported previously [21]. Lon-
gitudinal and transverse scans were performed, allowing 
the measurement of the depth, the width and the length 
of each lobe. The volume of each lobe was calculated by 
the ellipsoid formula (volume in ml = 0.479 × maximum 
thickness × maximum length × maximum width). Total 
thyroid volume was the sum of both lobes, and the isth-
mus was not included. The diagnosis of hyperthyroidism 
was not previously known in any of the studied persons. 
In all cases determining thyroid volume, when it was 
increased or there were nodes over 2 cm in diameter, one 
of the authors (MKH) assessed the signs and symptoms 
of hyperthyroidism and recommended measuring TSH 
and T4. Hyperthyroidism was not found in any of the 
studied individuals.
Statistical analysis
In order to evaluate the distribution of qualitative indi-
cators we calculated the manifestation frequency (%), 
whereas quantitative indicators, due to their nonpara-
metric distribution in many cases, were given as medians 
and 1–3 quartiles. Frequency of events was compared 
using Chi squared (Yates corrected). If at least one row 
of quantitative data had a non-normal distribution, then 
Kruskal–Wallis test was used, else we used ANOVA for 
comparisons of four groups. We also evaluated odds 
ratios (ORs) and corresponding 95  % confidence inter-
vals (CIs) in order to assess the risk of events in cross-
sectional studies using the model of logistic regression. 
ROC analysis was performed to assess the accuracy of 
models and to determine optimal cut-off thresholds. 
Youden index (sensitivity + specificity − 1) was used for 
determining the cut-off point. SPSS 11.0 and MedCalc v. 
15.6 (MedCalc Software Inc., Broekstraat, Belgium) soft-
ware packages were used for statistical analysis. All tests 
of significance were two tailed with the critical level of 
p = 0.05.
Results
From 196 men and women, 74 (37.8  %) demonstrated 
normal fasting glucose and glucose tolerance (NGT), and 
54 (27.6 %) had diabetic glucose levels in venous plasma 
(SDDM). Among them there were 25 persons (12.7  %), 
whose HbA1c level reached 6.5  %, hence were consid-
ered having chronic hyperglycemia—confirmed diabetes 
mellitus. Members of this group had higher, compar-
ing to others, levels of plasma glucose, had a more fre-
quent history of strokes and/or myocardial infarctions 
(p < 0.05) and all had arterial hypertension. The fraction 
of those, who starved during childhood in this group 
was smaller (p = 0.002), comparing to others. Sixty eight 
persons (34.7  %), according to glucose tolerance testing 
were assigned to impaired glucose regulation (IGR) cat-
egory or pre-diabetes. Distribution of these four catego-
ries (NGT; IGR; SDDM HbA1c < 6.5 %/HbA1c ≥ 6.5 %) 
among women and men was the same. Among anthro-
pometric indicators, increasing of glycaemia from NGT 
category to HbA1c ≥ 6.5 % in women is associated with 
elevation of BMI, WC, HC, WC/HC, NC (p < 0.05). For 
men this is true (p < 0.05) only concerning WC and WC/
HC ratio (Table 1).
We did not find any statistically significant difference of 
thyroid volume in categories, identified according to the 
results of glucose tolerance testing, however we did find a 
correlation of this indicator with NC: according to Spear-
man’s rank correlation coefficient Ro factor  =  0.278; 
N = 89; p < 0.01. Increase of NC among men and women 
in categories from normal blood glucose to diabetes mel-
litus is given in Fig. 1. There are also gender differences 
that manifest with greater NC among men.
For further analysis of SDDM risk, associated with NC 
we used ROC curve analysis. 1st category (NTG) and 4th 
category (HbA1c ≥ 6.5 %) were considered the most dis-
tinct concerning the presence or absence of SDDM and 
they were therefore evaluated separately. Cut-off value 
concerning NC, chosen using maximization of Youden 
index for women = 36.5 cm (Table 2).
Exceeding of this NC value indicated a higher statis-
tical possibility of falling into SDDM HbA1c  ≥  6.5  % 
category, and not into others, identified according to 
glycaemia and glucose tolerance screening results (area 
under curve-AUC  =  0.690  ±  0.064, p  =  0.003) with 
sensitivity 72.2  % (95  % CI 46.5–90.3  %) and specificity 
62.3 % (95 % CI 53.4–70.7 %). If we were to compare only 
SDDM HbA1c ≥  6.5  % and NTG categories, the corre-
sponding ROC values that indicate statistical significance 
of the test will only increase (AUC  =  0.800  ±  0.063, 
p < 0.0001) sensitivity 72.2 % (95 % CI 46.5–90.3 %) and 
specificity 79.3  % (95  % CI 65.9–89.2  %). Odds ratios 
(ORs) of diagnosing SDDM HbA1c ≥ 6.5 % for these two 
models, providing the use of NC cut off point > 36.5 cm 
are 4.3 (95  % CI 1.4–12.8), p  =  0.009 or 9.9 (95  % CI 
2.9–33.8), p  <  0.001 respectively. The use of male NC 
cut-off  >  38.5  cm in other statistical models has also 
proven its predictive value concerning SDDM diagnos-
tics: AUC = 0.774 ± 0.092, p = 0.003 and 0.803 ± 0.095, 
p = 0.003 (p value comparing to AUC = 0.5) in case of 
comparing HbA1c  ≥  6.5  % to all other categories, or 
Page 4 of 8Khalangot et al. Diabetol Metab Syndr  (2016) 8:12 
Table 1 Anthropometric and life style characteristics of rural residents (45+ years old, Kyiv region, Ukraine) belonging 
to different categories, created according to a results of the glucose tolerance screening
Categories/measurements NGT IGR: IFG and/or IGT SDDM, Hb A1c < 6.5 % SDDM, Hb A1c ≥ 6.5 % P
Both genders, n 74 68 29 25
Fasting glucose, mmol/l 5.6 (5.2–5.8) 6.3 (6.1–6.6) 7.4 (7.1–7.9) 8.1 (7.4–9.4) <0.001
Glucose tolerance test, mmol/l 5.5 (4.8–6.7) 6.8 (5.5–8.9) 7.9 (6.4–11.5) 12.6 (8.4–15.6) <0.001
HbA1c, %; n 5.25 (5.01–5.5); 2 5.8 (5.6–5.8); 14 5.9 (5.6–6.2); 29 7.3 (7.0–8.0); 25 <0.001
Insufficient physical activity, n (%) 6 (8.2) 4 (5.9) 6 (20.7) 5 (20.0) 0.061
First line relatives with diabetes, n (%) 14 (19.2) 14 (20.9) 6 (22.2) 4 (17.4) 0.970
Current smoking, n (%) 6 (8.1) 4 (5.9) 2 (6.9) 1 (4.0) 0.895
Alcohol consumption, n (%) 50 (68.5) 37 (54.4) 29 (62.1) 15 (60.0) 0.395
Stroke/MI history, n (%) 5 (6.8) 3 (4.5) 5 (17.2) 19 (76.0) <0.001
High blood pressure, n (%) 48 (64.9) 49 (72.1) 23 (79.3) 25 (100) 0.006
Parental family starvation, n (%) 48 (81.4) 44 (83) 16 (76.2) 13 (65) 0.364
Personal childhood starvation, n (%) 26 (89.7) 22 (100) 7 (77.8) 7 (53.8) 0.002
Thyroid volume, ml; n 12.4 (10.6–16.5); 25 13.5 (12.0–17.8); 32 15.7 (14.2–20.6); 12 17.2 (11.5–20.7); 15 0.245
Women, n 55 53 24 18 0.756
Fasting glucose, mmol/l 5.7 (5.3–5.8) 6.4 (6.2–6.6) 7.4 (7.1–7.9) 8.5 (7.4–9.9) <0.001
Glucose tolerance test, mmol/l 5.7 (5.0–6.8) 7.1 (5.6–8.9) 8.1 (6.6–11.6) 12.5 (8.1–15.7) <0.001
HbA1c, %; n – 5.8 (5.6–5.8); 14 5.9 (5.6–6.3); 24 7.5 (7.0–8.0); 18 <0.001
Insufficient physical activity, n (%) 3 (5.5) 2 (3.8) 4 (16.7) 3 (16.7) 0.109
Parental family starvation, n (%) 36 (83.7) 36 (81.8) 12 (75) 12 (80) 0.875
Personal childhood starvation, n (%) 20 (90.9) 18 (100) 5 (71.4) 6 (66.7) 0.045
1st line relatives with diabetes, n (%) 11 (20.4) 12 (23.1) 5 (21.7) 3 (50.0) 0.439
Current smoking, n (%) 1 (1.8) 1 (1.9) – – 0.852
Alcohol consumption, n (%) 36 (66.7) 28 (52.8) 15 (62.5) 9 (50.0) 0.412
High blood pressure, n (%) 39 (70.9) 45 (84.9) 20 (83.3) 18 (100) 0.035
Stroke/MI history, n (%) 3 (5.5) 3 (5.8) 4 (16.7) 5 (27.8) 0.021
Age, years 64 (57–74) 63 (56–71) 64 (55–72.5) 68 (60–73) 0.391
Height, cm 158 (154–163) 160 (154–162) 161.5 (155–166) 161.5 (155–164) 0.464
BMI, kg/m2 29.7 (25.5–33.3) 32.6 (28.9–36.7) 33.1 (28.8–37.2) 36.6 (31.2–40.4) 0.002
Neck circumference, cm 35 (33–36) 36 (34.5–38) 38 (36–39.3) 37.5 (36–40) <0.001
Waist circumference, cm 95 (88–103) 105 (98–111) 106 (97.5–114.5) 116 (105–130) <0.001
Hip circumference, cm 107 (101–117) 109 (102–117) 110.5 (101.5–121) 116 (112–129) 0.008
WC/HC 0.88 (0.83–0.95) 0.93 (0.90–0.98) 0.97 (0.89–1.00) 0.98 (0.95–1.04) 0.014
Thyroid volume, ml; n 12.2 (8.8–15.6); 19 13.5 (12.1–18.1); 25 15.4 (14.6–19.7); 9 15.2 (9.2–22.7); 10 0.173
Men, n 19 15 5 7
Fasting glucose, mmol/l 5.4 (4.7–5.9) 6.1 (5.6–6.3) 7.4 (7.3–7.4) 7.9 (6.6–9.4) <0.001
Glucose tolerance test, mmol/l 5.3 (4.3–6.1) 6.1 (5.1–9.1) 6.3 (6.0–7.4) 12.8 (8.4–15.6) <0.001
HbA1c, %; n – – 6.0 (5.6–6.1); 5 7.1 (7.0–8.3); 7 0.003
Insufficient physical activity, n (%) 3 (16.7) 2 (13.3) 2 (40) 2 (28.6) 0.549
Parental family starvation, n (%) 12 (75) 8 (88.9) 4 (80) 1 (20) 0.044
Personal childhood starvation, n (%) 6 (85.7) 4 (100) 2 (100) 1 (25) 0.045
First line relatives with diabetes, n (%) 3 (15.8) 2 (13.3) 1 (25.0) 1 (14.3) 0.953
Current smoking, n (%) 5 (26.3) 3 (20) 2 (40) 1 (14.3) 0.740
Alcohol consumption, n (%) 14 (73.7) 9 (60) 3 (60) 6 (85.7) 0.598
High blood pressure, n (%) 9 (47.4) 4 (26.7) 3 (60) 7 (100) 0.015
Stroke/MI history, n (%) 2 (10.5) – 1 (20) 1 (14.3) 0.459
Age, years 66 (56–75) 57 (49–78) 61 (59–70) 75 (61–79) 0.364
Height, cm 172 (167–176) 168 (164–172) 167 (167–174) 169 (161–180) 0.294
BMI, kg/m2 27.3(24.1–31.1) 28.1 (25.1–33.7) 31.4 (29.0–31.7) 31.9 (29.6–35.9) 0.172
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just to NTG. Among men, the indicated models dem-
onstrated 100  % (95  % CI 54, 1–100  %) sensitivity, but 
low specificity: 38.5 % (95 % CI 23.4–55.4 %) and 52.6 % 
(95 % CI 28.9–75.6 %). Assessment according to logistic 
regression model of gender-adjusted chances of falling 
into T2D HbA1c ≥ 6.5 % versus NTG categories that are 
associated with an increase of NC, indicates a preserva-
tion of their statistical significance, and sometimes its 
increase after additional adjusting by personal history 
(models #1, 2) or anthropometric characteristics (models 
#3–6); see Table 3.
Comparing corresponding areas under curves (AUCs), 
built according to models 0–6 indicates that there are no 
differences between models #1–6 and model #0 (Addi-
tional file 1: Fig. S1; Additional file 2: Fig. S2).
Discussion
Thus, in a relatively small (n  =  196) cross-sectional 
study, recently conducted among residents of rural 
Ukraine, aged over 44 y.o., based on standard glucose 
tolerance testing, we found a substantial fraction of 
persons (27.6  %) with diabetic plasma glucose levels, 
and 12.7 % were diagnosed with diabetes (confirmed by 
HbA1c  ≥  6.5  %). 37.8  % of persons demonstrated nor-
mal fasting glucose, along with normal glucose tolerance, 
whereas 34.7 % were identified as prediabetic, according 
to glucose tolerance testing. Unfortunately Ukraine had 
no epidemiologic studies, involving prevalence of T2D/
IgR or impaired glucose tolerance after introduction of 
current WHO (1999) blood glucose diabetes/IGR crite-
ria, therefore we could only use data from other countries 
for comparison. According to recent epidemiologic data 
from International Diabetes Federation [22], worldwide 
prevalence of diabetes mellitus grows from around 11 % 
at 45 y.o. to 20  % at 75 y.o. A very large Chinese study 
[23], the design of which (oral glucose-tolerance test 
performed in randomly selected and population-based 
cohort) was similar to ours, showed a prevalence of 
20.4 % for those aged 60 and above [23].
Considering the fact that in the four categories that 
we identified according to glucose tolerance testing, the 
age medians fluctuated from 57 to 75 years for men and 
from 63 to 68  years for women, the quantitative glu-
cose tolerance test-based distribution of persons among 
the categories does not look impossible or improbable. 
Considering a small scale of our study, as well as some 
practical considerations, we have isolated the category 
of persons with “diabetic” fasting and/or standard glu-
cose loading levels and HbA1c ≥ 6.5 %. In other words, 
Table 1 continued
Categories/measurements NGT IGR: IFG and/or IGT SDDM, Hb A1c < 6.5 % SDDM, Hb A1c ≥ 6.5 % P
Neck circumference, cm 38.5 (36.5–41.5) 39 (37–42) 42 (40–43) 42.5 (40–44) 0.063
Waist circumference, cm 97 (90–104) 96 (89–109) 108 (99–112) 114 (111–116) 0.029
Hip circumference, cm 100 (96–109) 101.5 (98–108) 97 (97–109) 107 (104–114) 0.315
WC/HC 0.96 (0.93–1.01) 0.97 (0.93–1.02) 1.01 (1.01–1.02) 1.03 (1.01–1.07) 0.026
Thyroid volume, ml; n 14.5 (11.9–28.2); 6 13.5 (11.9–17.5); 7 20.7 (13.9–26.1); 3 17.2 (12.1–20.7); 5 0.655
Data are given as number of persons (percentages) or medians (1, 3 quartiles)
Fig. 1 Neck circumference (cm) of rural residents (45+ years old, Kyiv 
region, Ukraine) belonging to different categories, created according 
to a results of the glucose tolerance screening. Shown are medians 
and 95 % CI. Top panel (black globes)—women, low panel (white 
globes)—men. 1—NGT; 2—IGR; 3—“Diabetic” glucose levels and Hb 
A1c < 6.5 %; 4—HbA1c ≥ 6.5 %. 95 % CI for the 3rd male category 
not given due to insufficient number of persons in this group
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chronic hyperglycemia (diabetes mellitus) in this group 
(group 4) was better confirmed, than in group 3 (“Dia-
betic” glucose levels, HbA1c < 6.5 %). Group 4 was later 
used to build statistical models to assess the chances of 
detecting diabetes during screening that were associated 
with questionnaire or anthropometric data. As far as we 
know, such approach to classification of subjects was not 
previously used.
Thus, our classification (1—NGT; 2—IGR; 3—“Dia-
betic” glucose levels and HbA1c  <  6.5  %; 4—
HbA1c  ≥  6.5  %), despite a relatively small number of 
persons, is confirmed by results of biochemical tests 
(higher levels of plasma glucose in group HbA1c ≥ 6.5 % 
Table 2 Comparison of sensitivity, specificity, youden index of screen-detected T2D (HbA1c ≥ 6.5 %), with different neck 
circumference point
Neck circumference, cm SDDM HbA1c ≥ 6.5 % vs. all other study categories SDDM HbA1c ≥ 6.5 % vs. NGT
Sensitivity (%) Specificity (%) Youden index Sensitivity (%) Specificity (%) Youden index
Women
 ≥29 100.0 0.0 0.00 100.0 0.0 0.00
 >31 100.0 6.2 0.06 100.0 13.2 0.13
 >32 94.4 10.0 0.04 94.4 18.9 0.13
 >33 94.4 18.5 0.13 94.4 26.4 0.21
 >34 88.9 29.2 0.18 88.9 39.6 0.29
 >34.5 88.9 31.5 0.20 88.9 43.4 0.32
 >35 83.3 45.4 0.29 83.3 60.4 0.44
 >36 72.2 61.5 0.34 72.2 77.4 0.50
 >36.5 72.2 62.3 0.35 72.2 79.3 0.51
 >37 50.0 73.1 0.23 50.0 88.7 0.39
 >37.5 50.0 74.6 0.25 50.0 90.6 0.41
 >38 33.3 82.3 0.16 33.3 90.6 0.24
 >38.5 33.3 83.9 0.17 33.3 94.3 0.28
 >39 27.8 90.8 0.19 27.8 96.2 0.24
 >39.5 27.8 91.5 0.19 0.00
 >40 22.2 93.9 0.16 22.2 100.0 0.22
 >40.5 16.7 93.9 0.11 – – –
 >41 5.6 94.6 0.00 – – –
 >42 0.0 97.7 0.98 0.0 100.0 0.00
 >44 0.0 100.0 0.00 – – –
Men
 ≥35 100.0 0.0 0.00 100.0 0.0 0.00
 >38.5 100.0 38.5 0.38 100.0 52.6 0.53
 >39 83.3 51.3 0.35 83.3 52.6 0.36
 >40 66.7 66.7 0.33 66.7 68.4 0.35
 >41.5 66.7 71.8 0.38 66.7 79.0 0.46
 >42 50.0 84.6 0.35 50.0 89.5 0.39
 >43 33.3 89.7 0.23 33.3 89.5 0.23
 >44 16.7 100.0 0.17 16.7 100.0 0.17
 >45 0.0 100.0 0.00 0.0 100.0 0.00
Table 3 Logistic regression multivariable evaluating 
of SDDM HbA1c ≥ 6.5 % vs. NGT category neck circumfer-
ence risk
OR’s calculated for the NC unit (cm) as continued variable
Models # and their adjusting OR (95 % CI) P
0 Gender 1.60 (1.27–2.02) <0.001
1 Gender + stroke/MI history 1.59 (1.26–2.01) <0.001
2 Gender + personal childhood starvation 1.92 (1.25–2.97) 0.003
3 Gender + BMI 1.43 (1.05–1.96) 0.024
4 Gender + WC/HC 1.53 (1.21–1.94) <0.001
5 Gender + high blood pressure 1.57 (1.21–2.03) <0.001
6 Gender + thyroid volume 2.01 (1.20–3.38) 0.008
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vs. HbA1c < 6.5 %), anthropometric measurements (BMI, 
WC, HC, HC, WC/HC, NC), as well as questionnaire 
data/BP measurements (stroke/MI history; high BP; per-
sonal childhood starvation). A positive relation of most of 
these factors with T2D risk is well known [24, 25]. Asso-
ciation of NC or childhood starvation with SDDM risk 
could be considered new data. The latter factor deserves 
to be analyzed separately therefore in this study it was 
considered only as one of the causes that could poten-
tially influence the correlation between NC and diabetes 
risk.
We believe that an increase of NC in men and women 
starting from normal plasma glucose group and ending 
with diabetes mellitus group that is statistically significant 
for women (<0.001), and is a tendency for men (Table 1; 
Fig.  1), are the most interesting results of this study. 
According to Receiver Operating Characteristics (ROC) 
analysis, the statistically significant NC cut-off points 
for women and men were 36.5 and 38.5 accordingly, and 
reaching/exceeding these values would indicate a statisti-
cally significant risk of having SDDM. Recently a team of 
researchers from China [9] confirmed that NC ≥ 37 cm 
for men and ≥ 33 for women were the best cut-off points 
for metabolic syndrome, however the presence of diabe-
tes mellitus was not determined in this study [9]. Using 
the obtained in our study NC cut-off point for women as 
a categorical variable allowed to evaluate the correspond-
ing OR = 9.9 (95 % CI 2.9–33.8).
Performed chance assessment of finding screen-
detected diabetes, associated with an increase of NC by 
univariate and multivariate logistic regression analyses 
in models that were adjusted for gender and anthropo-
metric (BMI, WC/HC, thyroid volume) or other (stroke/
MI; childhood starvation history; high BP) confounders, 
confirmed independent nature of this risk factor. Gen-
der-adjusted OR, determined by an increase of NC as 
a continued variable equaled to 1.60 (1.27–2.02). As far 
as we know, there were no previous risk assessments for 
screen-detected T2D, associated with NC. In a cross-sec-
tional study of 43,595 women participating in the Take 
Off Pounds Sensibly Club, those with a self-reported 
neck circumference in the top tertile were found to have 
a twofold increased risk of diabetes relative to those in 
the bottom tertile, even after adjustment for other meas-
ures of adiposity (BMI, WC/HC) [3]. Our study is popu-
lation-based and is set up on our own measurements that 
included glucose tolerance testing, anthropometric data, 
and thyroid volume.
Studies, that assessed the significance of neck circum-
ference in the context of cardiometabolic risk indicate 
that NC is associated with CVD risk factors even after 
adjustment for multidetector computed tomography 
assessed visceral adipose tissue [7] and measured by 
dual-energy X-ray absorptiometry head fat was positively 
corrected with NC in males but not females. There was 
no significant correlation between head fat and fasting 
plasma glucose [26].
In prospective, community-based cohort study of 
Korean adults, it was found that the highest quartile of 
neck circumference was associated with a 1.746- and 
2.077-fold higher risk of DM development in men and 
women respectively, after adjusting for various factors 
that are known to affect glucose metabolism. [10].
In our study we managed to show SDDM risk, in a 
cross-sectional population-based study of adults in 
rural Ukraine, adjusted by ThV and childhood starvation 
history.
One of the more evident explanations of association 
between NC and diabetes risk could be sleep disorders 
and/or obstructive sleep apnea (OSA), associated with 
an increase of NC, as it was recently demonstrated that 
OSA is a predictor of abnormal glucose metabolism in 
chronically sleep deprived obese adults [6], a high NC is 
a predictor of metabolic syndrome and obstructive sleep 
apnea in short-sleeping obese men and women [27]. 
However in a study of Cho et al. [10], daytime sleepiness 
and snoring habit were not associated with incidence of 
SDDM and did not change the association of NC with 
SDDM [10].
Furthermore, hypoxia exposure has been shown to 
exert beneficial effects on glucose homeostasis and insu-
lin sensitivity in humans, but underlying mechanisms 
have not yet been studied in detail [28].
Conclusion
Neck circumference measurement during screen-based 
investigation of glycaemia and glucose tolerance led to 
unveiling of a new risk factor of screen-detected diabetes, 
which is independent from other indicators of adipose 
tissue distribution as well as from the thyroid volume. 
Future studies are needed to understand the nature of 
this connection and to better assist the diabetes preven-
tion possibilities.
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